Aaron Pearce
Analyst · Robert W. Baird
Thank you, Michael. Good morning, everyone. The financial review starts on Slide 3, total sales increased 2.5% to $289.2 million in the fourth quarter, which consisted of a 3% increase in organic sales and a 0.5% decline due to foreign currency translation. We are heavily focused on driving efficiencies throughout the organization and our fourth quarter results reflect this focus. At the same time, we are increasing our investment in innovation. The increased R&D spent by 19% this quarter and this is an area where we also expect to see year-over-year increases in the future. Our pretax earnings increased 12% to $35.9 million compared to $32 million in last year's fourth quarter. Last year we benefited from a lower than normal 21.5% tax rate in the fourth quarter, whereas our tax rate was 29.7% in the fourth quarter of this year. Looking forward to fiscal 2018, we expect our full year income tax rate to be in a historical range of 27% to 29%. Diluted earnings per share finished at $0.48 this quarter compared to $0.49 in a fourth quarter of last year. Our cash generation was also very strong as cash flow from operating activities was more than doubled net earnings this quarter. Overall, we finished fiscal 2017 strong as we had accelerating organic sales growth. We've realized nice efficiency gains in our G&A structure and we had strong cash generation, all while ramping up our investments in R&D. On Slide 4, you will find a summary of our quarterly sales trend. As you can see from this chart, our fourth quarter revenue was the highest we've seen over the last two years and our organic growth rate was also the highest we've seen in quite some time. Although, global currencies have recently strengthened versus the US dollar, during our fiscal fourth quarter that ran from May 1st to July 31st, the dollar was still stronger than it was in the prior year resulting in a modest 0.5% decline in revenue from foreign currency translation. This quarter we did benefit from approximately 0.6 additional billing days as well. Organic sales per day grew 2% in the fourth quarter. Slide 5 provides an overview of our gross profit margin trending. We finished our fourth quarter with a gross profit margin of 49.7%, which was a 30 basis point decline compared to the fourth quarter of last year. The decline in our gross profit margin this quarter was due primarily to the pricing challenges in our North American WPS business. On Slide 6, you will find a trending our SG&A expense. SG&A was $96.5 million this quarter compared to $98.4 million in the fourth quarter of last year. Approximately 25% of this year-over-year decline in SG&A was due to foreign currency translation, while the remaining three quarters of the reduction was a result of the team's focused effort to identify and drive efficiency. Slide 7 summarizes our diluted earnings per share which finished at $0.48 this quarter compared to diluted EPS of $0.49 in the fourth quarter of last year. As I mentioned, the fourth quarter of last year benefited from a lower than normal tax rate. If our fourth quarter tax rate would have been consistent between fiscal 2016 and fiscal 2017, our fourth quarter EPS would have increased by approximately 10%. Moving along to Slide 8. You'll see a summary of our cash generation. This quarter, we generated $52.9 million of cash flow from operating activities, compared to $40.4 million generated in the fourth quarter of last year. Looking at free cash flow, we generated $48.6 million this quarter, compared to $30.8 million in last year’s fourth quarter. Our fourth quarter cash generation benefited from the timing of certain payments between our third and fourth quarter this year. We remain focused on cash generation and we are consistently generating free cash flow in excess of net earnings. In the fourth quarter, our primary uses of cash were to invest in organic sales generating activities, to strengthen balance sheet by paying down debt and to pay dividends to our shareholders, which brings us to slide number nine. These slide shows the trending of our net debt position and provides a snapshot of debt structure at the end of this fiscal year. At July 31, we were in a net cash position of $26.2 million, compared to a net debt of $75.7 million at the start of this fiscal year. This is more than a $100 million reduction net debt this year, which is a testament to our strong cash generation. As we look at deploying our cash. Our capital allocation approach is disciplined and patient. First, we use our cash to fund organic growth opportunities, which includes funding investments in new product development, IT improvements, capability enhancing capital expenditures et cetera. Second, we focused on returning cash to our shareholders in the form of dividend. In fact, yesterday we announced our 32nd consecutive year of annual dividend increases. After funding organic growth investments and dividend, we then patiently deploy our cash in a disciplined manner for acquisitions where we believe we have strong synergistic opportunities. And we'll use our cash to improve shareholder returns through opportunistic share purchases. We currently have two million shares authorized for repurchase. Overall, our cash generation is strong. Our balance sheet is strong and we are focused on driving further long-term value to our shareholders through a disciplined and patient allocation of capital. Before moving to our F'2018 guidance, let me provide a look back at our financial results for our full fiscal year ended July 31, 2017 which is on slide 10. This year we returned through organic sales growth, we increased our pretax earnings by 16%. We increased net earnings by 19%. And we generated $144 million of cash flow from operating activities, which equates to approximately 151% of net earnings. We also improved our gross profit margin by 20 basis points and we are successful of executing efficiency gains in our SG&A structure which resulted in $17.4 million decrease in the absolute dollar amount of SG&A spent. As a percent of sales, SG&A declined from 36.2% last year to 34.8% this year. A reduction in SG&A have been focused on G&A expense, back office selling activities and improving our processes around the overall customer buying experience. We've more work to do in this area but we are seeing some nice results from our efforts. As we drive efficiencies and operations in our G&A structure, we are also investing in R&D. R&D spend was up 11% this year which is consistent with our strategy for driving long-term sales growth by building an innovation focused culture and an efficient new product development process. Overall, our F'17 financial results were quite strong and we set the foundation for a future success through more simplified cost structure, a renewed sense of local ownership and accountability and increasing benefits from our long-term investment and innovation. The next slide, Slide 11 introduces guidance for our fiscal year ending July 31, 2018. We expect earnings per diluted Class A Nonvoting Common Share to range from $1.85 to $1.95 and we expect low single digital organic sales growth for the year ending July 31, 2018. When comparing our F'18 guidance range to where we just finished fiscal 2017, it's important to remember that we had an unusually low income tax rate of 24.5% in fiscal 2017 due to certain non-cash tax benefits resulting from our second quarter cash repatriation that we don't expect to repeat in fiscal 2018. In F'18, we expect our tax rate to return to our historical range of 27% to 29%. If our fiscal 2017 tax rate would have been closer to our historical average of 28%, then our diluted EPS would have been $1.75 last year, so it's normalized tax rate our F'18 guidance range of $1.85 to $1.95 per share represents EPS growth of between $0.10 and $0.20 over fiscal 2017. In addition, in fiscal 2018, we expect to increase our R&D investment by another 10% when compared to fiscal 2017. Offsetting this increase in R&D spend in the more normalized tax rate are our ongoing efficiency gains in our manufacturing facilities and in our SG&A cost structure. Other key operating assumptions in our guidance are depreciation and amortization of approximately $26 million and capital expenditures of approximately $30 million. Included in our capital expenditure plan is approximately $10 million for the purchase of certain strategic facilities and the remaining $20 million is primarily for enhancement to equipment to improve our capabilities or drive efficiency gain. We are not anticipating any restructuring charges and we are not excluding any one time items from this guidance. I'll now turn the call back over to Michael to cover our platform results and provide some closing comments before turning the call over to Q&A. Michael?